| Literature DB >> 31879281 |
Matias A Avila1, Jean-François Dufour2, Alexander L Gerbes3, Fabien Zoulim4, Ramon Bataller5, Patrizia Burra6, Helena Cortez-Pinto7, Bin Gao8, Ian Gilmore9, Philippe Mathurin10, Christophe Moreno11, Vladimir Poznyak12, Bernd Schnabl13, Gyongyi Szabo14, Maja Thiele15, Mark R Thursz16.
Abstract
Alcohol-related liver disease (ALD), which includes a range of disorders of different severity and is one of the most prevalent types of liver disease worldwide, has recently regained increased attention. Among other reasons, the realisation that any alcohol intake, regardless of type of beverage represents a health risk, and the new therapeutic strategies tested in recently published or undergoing clinical trials spur scientific interest in this area.In April 2019, Gut convened a round table panel of experts during the European Association for the Study of the Liver International Liver Congress in Vienna to discuss critical and up-to-date issues and clinical trial data regarding ALD, its epidemiology, diagnosis, management, pathomechanisms, possible future treatments and prevention. This paper summarises the discussion and its conclusions. © Author(s) (or their employer(s)) 2020. No commercial re-use. See rights and permissions. Published by BMJ.Entities:
Keywords: alcohol; alcoholic liver disease; cirrhosis; fibrosis; liver transplantation
Mesh:
Year: 2019 PMID: 31879281 PMCID: PMC7236084 DOI: 10.1136/gutjnl-2019-319720
Source DB: PubMed Journal: Gut ISSN: 0017-5749 Impact factor: 23.059